| Literature DB >> 23054875 |
Kenneth C Anderson1, Melissa Alsina, William Bensinger, J Sybil Biermann, Adam D Cohen, Steven Devine, Benjamin Djulbegovic, Edward A Faber, Christine Gasparetto, Francisco Hernandez-Ilizaliturri, Carol Ann Huff, Adetola Kassim, Amrita Y Krishnan, Bruno C Medeiros, Ruby Meredith, Noopur Raje, Jeffrey Schriber, Seema Singhal, George Somlo, Keith Stockerl-Goldstein, Steven P Treon, Guido Tricot, Donna M Weber, Joachim Yahalom, Furhan Yunus, Rashmi Kumar, Dorothy A Shead.
Abstract
These NCCN Guidelines Insights highlight the important updates/changes specific to the management of Waldenström's Macroglobulinemia/Lymphoplasmacytic Lymphoma. These include the addition of regimens containing novel agents as primary and salvage therapy options, inclusion of the updated summary of response categories and criteria from the sixth international workshop on Waldenström's Macroglobulinemia, and a section on management of peripheral neuropathy in the accompanying discussion.Entities:
Mesh：
Substances：
Year: 2012 PMID： 23054875 DOI： 10.6004/jnccn.2012.0128
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908